Details for New Drug Application (NDA): 022165
✉ Email this page to a colleague
The generic ingredient in CAMBIA is diclofenac potassium. There are forty-seven drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.
Summary for 022165
Tradename: | CAMBIA |
Applicant: | Assertio |
Ingredient: | diclofenac potassium |
Patents: | 4 |
Pharmacology for NDA: 022165
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 022165
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165 | NDA | Assertio Therapeutics, Inc. | 13913-011 | 13913-011-19 | 9 PACKET in 1 CARTON (13913-011-19) / 1 POWDER, FOR SOLUTION in 1 PACKET (13913-011-01) |
CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165 | NDA | Assertio Therapeutics, Inc. | 13913-012 | 13913-012-02 | 9 PACKET in 1 CARTON (13913-012-02) / 1 POWDER, FOR SOLUTION in 1 PACKET |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | 50MG | ||||
Approval Date: | Jun 17, 2009 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jun 16, 2026 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jun 16, 2026 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jun 16, 2026 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS |
Expired US Patents for NDA 022165
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription